Zelira Therapeutics was formerly known as Zelda Therapeutics, a Perth-based biotechnology company formed to bring together some of the world’s leading researchers and clinicians active in the study and use of medicinal cannabis to treat a variety of ailments.
The company listed on the ASX in October 2016, through the reverse takeover of Gleneagle Gold.
In December 2019, Zelda Therapeutics acquired Ilera Therapeutics and changed its name to Zelira Therapeutics.
Contact Details
Level 3, 101 St Georges Terrace
,
PERTH
WA
6000
08 6558 0886
enquiries@zeliratx.com
